1-5 of 5
John M. Fastenau, MPH, RPh
Close
Sort by
Journal Articles

Greater Area under the Hemoglobin Change Curve Is Associated with Improved Outcomes in Elderly Patients Receiving Epoetin Alfa for Chemotherapy-Related Anemia.

Scott R. McKenzie, MD, Mei S. Duh, MPH, ScD, Patrick Lefevbre, MA, John M. Fastenau, MPH, RPh, Catherine Tak Piech, MBA
Journal: Blood
Blood (2004) 104 (11): 3146.
https://doi.org/10.1182/blood.V104.11.3146.3146
Published: 2004
Journal Articles

Dosing Patterns of Erythropoietic Agents and Their Association with Provider Visits in Patients with Cancer and Anemia.

Susan C. Bolge, PhD, John M. Fastenau, MPH, RPh, Jamie B. Howell, PharmD, MS, Catherine T. Piech, MBA, Jane A. Donohue, PhD
Journal: Blood
Blood (2004) 104 (11): 5306.
https://doi.org/10.1182/blood.V104.11.5306.5306
Published: 2004
Journal Articles

Early Results from a Choice Based Conjoint Analysis Assessing Patient Preferences for Selected Features of Erythropoietic Agents.

Susan C. Bolge, PhD, John M. Fastenau, MPH, RPh, Jamie B. Howell, PharmD, MS, Catherine T. Piech, MBA, Jane A. Donohue, PhD
Journal: Blood
Blood (2004) 104 (11): 5307.
https://doi.org/10.1182/blood.V104.11.5307.5307
Published: 2004
Journal Articles

Utilization Trends of Epoetin Alfa and Darbepoetin Alfa in Adult Patients with Cancer Receiving Chemotherapy in Community Practice Settings.

Ted Coletti, PhD, Jamie B. Howell, PharmD, MS, Karen Todoroff, MPH, Keith L. Gregory, PhD, John M. Fastenau, MPH, RPh
Journal: Blood
Blood (2004) 104 (11): 5313.
https://doi.org/10.1182/blood.V104.11.5313.5313
Published: 2004
Journal Articles

Benefits of Early Hemoglobin Response to Epoetin Alfa in Elderly Patients with Chemotherapy-Related Anemia.

James Rosberg, PhD, MBA, Pierre Y. Cremieux, PhD, Scott R. McKenzie, MD, John M. Fastenau, MPH, RPh, Catherine T. Piech, MBA
Journal: Blood
Blood (2004) 104 (11): 2216.
https://doi.org/10.1182/blood.V104.11.2216.2216
Published: 2004